The market is inclusive of branded GLP-1 products such as semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro, Zepbound), liraglutide (Victoza, Saxenda), and dulaglutide (Trulicity)
Promotes Heart Health: Helps lower triglycerides and improves circulation, reducing the risk of heart disease
Regulation of ferroptosis-related signaling pathways in cancer drug resistance GPX4 and FSP1 signaling As mentioned earlier, GPX4 is a GSH-dependent ferroptosis inhibitor that reduces lipid peroxides, whereas FSP1 functions independently of GSH, which acts as an oxidoreduction enzyme reducing coenzyme Q (CoQ) to ubiquinol (CoQH2) at the cell membrane
They enhance nitric oxide bioavailability, resulting in improved coronary blood flow and myocardial perfusion [4]